An 89-year-old man with coronary artery disease, hypertension, and gout was diagnosed with hepatocellular carcinoma in February 2017. In fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (^18^F-FDG PET/CT) study in September 2017, he was noted to have posterior layering of ^18^F-FDG in the urinary bladder \[Refer to Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\] in addition to the multiple metabolically active lesions in the liver and lungs.

![The urine with 18F-FDG is seen layered to the urine without ^18^F-FDG in the urinary bladder (a:axial CT view; b: axial pet view; fused PET/CT view)](IJNM-33-165-g001){#F1}

![Other fused PET/CT images demonstrating 18F-FDG layering in the urinary bladder (a: sagittal view; b: coronal view)](IJNM-33-165-g002){#F2}

The incidence of this physiological phenomenon is reported to be 4%. There are few hypotheses for this phenomenon. One hypothesis suggests the delayed urinary excretion of ^18^F-FDG and the delayed mixing of urine-containing ^18^F-FDG with nonradioactive urine. This layering is more likely to occur in patients with the distended bladder.\[[@ref1]\] Another hypothesis suggests that the layering of ^18^F-FDG in the urinary bladder is due to sedimentation of metabolically active cellular components such as inflammatory cells, malignant cells, or bacteria.\[[@ref2][@ref3]\] In this case, there were neither symptoms nor clinical evidence that the patient had urinary tract infection. For ^18^F-FDG PET/CT studies with intravenous iodinated contrast, the reversal of layering occurs where ^18^F-FDG has layered anteriorly. This is due to the displacement of urine with ^18^F-FDG by the urine-containing iodinated contrast.\[[@ref4]\] The commonly seen fusion error due to urinary bladder filling changes is easily distinguishable from posterior layering of ^18^F-FDG in the urinary bladder.\[[@ref5]\] Knowledge of this phenomenon is important to avoid misinterpretation and unnecessary investigations. However, delayed imaging of the bladder would be the appropriate method for further clarification if bladder pathology is suspected.\[[@ref6]\]
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